Psychology & Intimacy Groundbreaking Neuroinflammation Study Identifies Existing Drug Target to Combat Brain Disorders and Neurodegeneration October 8, 2026 Rebecca Shoemaker Medical science may stand on the brink of a major therapeutic breakthrough following the publication of a new study in the academic journal Brain. Led by Professor Nicholas Barnes at…
Sexual Health & Medical Wellness Johns Hopkins researchers develop innovative intranasal DNA vaccine to combat drug-tolerant tuberculosis bacteria October 7, 2026 Susilo Ahmad A collaborative team of scientists from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health has unveiled a novel therapeutic DNA vaccine candidate designed to revolutionize the…
Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Novel Intranasal DNA Vaccine to Combat Drug-Tolerant Tuberculosis Persisters September 28, 2026 Susilo Ahmad Tuberculosis remains a formidable global health crisis, persisting as one of the deadliest infectious diseases in human history despite six millennia of coexistence with our species. A team of researchers…
Sexual Health & Medical Wellness Breakthrough Intranasal DNA Vaccine Offers New Hope for Eradicating Drug-Tolerant Tuberculosis Persisters September 12, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have unveiled a pioneering experimental therapeutic DNA vaccine that could fundamentally shift the paradigm of tuberculosis…
Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Experimental Intranasal DNA Vaccine Targeting Drug-Tolerant Tuberculosis Bacteria July 19, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have unveiled a groundbreaking experimental therapeutic DNA vaccine for tuberculosis (TB), delivered non-invasively through the nose.…
Sexual Health & Medical Wellness Zoliflodacin Emerges as a Potential Game-Changer in the Global Fight Against Drug-Resistant Gonorrhea July 17, 2026 Susilo Ahmad Researchers are heralding a significant breakthrough in the treatment of gonorrhea, a widespread sexually transmitted infection, with a new oral medication named zoliflodacin demonstrating remarkable efficacy in late-stage clinical trials.…
Psychology & Intimacy Prucalopride, a Chronic Constipation Drug, Shows Promise in Alleviating Lingering Cognitive Deficits in Depression July 16, 2026 Rebecca Shoemaker People grappling with depression often find that even after their mood significantly improves, they are left with a persistent burden of cognitive challenges. These lingering symptoms can include profound memory…
Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Novel Intranasal DNA Vaccine Targeting Drug-Tolerant Tuberculosis July 12, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have achieved a significant breakthrough in the fight against tuberculosis (TB), developing an experimental therapeutic DNA…
Sexual Health & Medical Wellness Zoliflodacin Emerges as Promising Single-Dose Oral Treatment Against Growing Threat of Drug-Resistant Gonorrhea July 10, 2026 Susilo Ahmad Researchers are testing a new oral medication called zoliflodacin that could offer a simpler way to treat gonorrhea, especially strains that no longer respond well to existing antibiotics. In a…
Sexual Health & Medical Wellness Johns Hopkins Researchers Develop Novel Intranasal DNA Vaccine Targeting Drug-Tolerant TB Bacteria, Offering New Hope Against Global Health Scourge. July 5, 2026 Susilo Ahmad Researchers at Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health have achieved a significant breakthrough in the fight against tuberculosis (TB), developing an experimental therapeutic DNA…
